(Total Views: 480)
Posted On: 01/13/2020 12:44:25 PM
Post# of 149091
From today's PR:
"We look forward to working with the FDA and continuing to provide additional data that further supports leronlimab as a potential treatment option for patients."
The FDA has seen the data so my guess is they issued the invitation to apply for BTD.
"We look forward to working with the FDA and continuing to provide additional data that further supports leronlimab as a potential treatment option for patients."
The FDA has seen the data so my guess is they issued the invitation to apply for BTD.
(2)
(0)Scroll down for more posts ▼
